
Loading, please wait...

Loading, please wait...

A study explored the efficacy of dual antiplatelet therapy (DAPT) in old-old patients compared with younger patients with stroke. Of all the 6412 patients, 406 were old-old, 2755 were young-old and 3251 were younger. It was found that old-old patients had higher risks of composite vascular events, disabling stroke, bleeding & mortality within 90 days. Further, genotype-guided DAPT might not be as effective in old-old patients as in younger ones.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study explored the efficacy of dual antiplatelet therapy (DAPT) in old-old patients compared with younger patients with stroke. Of all the 6412 patients, 406 were old-old, 2755 were young-old and 3251 were younger. It was found that old-old patients had higher risks of composite vascular events, disabling stroke, bleeding & mortality within 90 days. Further, genotype-guided DAPT might not be as effective in old-old patients as in younger ones.
2 months ago

Discover the crucial role of glymphatic dysfunction in stroke, where perivascular clearance failure and neuroinflammation exacerbate cerebral edema and post-stroke brain injury.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday